Oncolys BioPharma, Inc.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is 0.00% vs 0.00% in Dec 2025",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is 6.01% vs -45.16% in Dec 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Dec'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "3.10",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-420.70",
          "val2": "-452.90",
          "chgp": "7.11%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "3.00",
          "val2": "1.40",
          "chgp": "114.29%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-2.80",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-414.50",
          "val2": "-441.00",
          "chgp": "6.01%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-136,155.70%",
          "val2": "0.00%",
          "chgp": "-13,615.57%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is -9.24% vs -50.16% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is -22.15% vs 13.09% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "28.50",
          "val2": "31.40",
          "chgp": "-9.24%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-2,023.80",
          "val2": "-1,680.60",
          "chgp": "-20.42%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "5.20",
          "val2": "4.60",
          "chgp": "13.04%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-2.80",
          "val2": "-17.10",
          "chgp": "83.63%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-2,058.00",
          "val2": "-1,684.80",
          "chgp": "-22.15%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-70,905.50%",
          "val2": "-53,575.20%",
          "chgp": "-1,733.03%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ

Mar'26

Dec'25

Change(%)

Net Sales

3.10

0.00

Operating Profit (PBDIT) excl Other Income

-420.70

-452.90

7.11%

Interest

3.00

1.40

114.29%

Exceptional Items

0.00

-2.80

100.00%

Consolidate Net Profit

-414.50

-441.00

6.01%

Operating Profit Margin (Excl OI)

-136,155.70%

0.00%

-13,615.57%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Mar 2026 is 0.00% vs 0.00% in Dec 2025

Consolidated Net Profit

QoQ Growth in quarter ended Mar 2026 is 6.01% vs -45.16% in Dec 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

28.50

31.40

-9.24%

Operating Profit (PBDIT) excl Other Income

-2,023.80

-1,680.60

-20.42%

Interest

5.20

4.60

13.04%

Exceptional Items

-2.80

-17.10

83.63%

Consolidate Net Profit

-2,058.00

-1,684.80

-22.15%

Operating Profit Margin (Excl OI)

-70,905.50%

-53,575.20%

-1,733.03%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is -9.24% vs -50.16% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is -22.15% vs 13.09% in Dec 2024

All Annual Results